Universe Pharmaceuticals (UPC) Current Assets (2020 - 2025)

Universe Pharmaceuticals (UPC) has 6 years of Current Assets data on file, last reported at $53.6 billion in Q3 2025.

• For the quarter ending Q3 2025, Current Assets rose 3.81% year-over-year to $53.6 billion; the trailing twelve-month figure through Sep 2025 stood at $53.6 billion (up 3.81% YoY), and the FY2025 full-year result was $53.6 billion, up 3.81% from the prior year.
• Current Assets improved to $53.6 billion in Q3 2025, from $51.6 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $53.6 billion in Q3 2025 to a low of $25.3 million in Q3 2023.
• A 5-year average of $13.2 billion and a median of $51.1 million in 2021 frame the typical range for Current Assets.
• Across the five-year window, Current Assets plunged 100.0% in 2021 and surged 204246.6% in 2024, its largest moves.
• Tracing UPC's Current Assets over 5 years: stood at $50.5 million in 2021, then decreased by 17.78% to $41.5 million in 2022, then slumped by 39.12% to $25.3 million in 2023, then surged by 204246.6% to $51.6 billion in 2024, then advanced by 3.81% to $53.6 billion in 2025.
• Business Quant data shows UPC's Current Assets at $53.6 billion in Q3 2025, $51.6 billion in Q3 2024, and $33.5 million in Q1 2024.